Clinical Trials on Human Characteristics in Italy

Total 305 results

Università Vita-Salute San Raffaele
Alessia Santoni; Sara Stottmeier; Klara Hemmerich; Giuseppe Di Dona; Luigi Ferini-Strambi

Recruiting

Investigating the Plasticity of Human Predictive Coding Through Neuromodulation (PREDICOM)

Human Brain and Cognition

Italy
Università Vita-Salute San Raffaele

Recruiting

An EEG Study on the Rhythmic Nature of Perception and Attention

Human Brain and Cognition

Italy
University of Bari
University of Bologna; Federico II University; University Of Perugia; University... and other collaborators

Unknown

Microbiota and Related Metabolome in Omnivore, Vegetarian or Vegan Diets (MRMOVVD)

Diet and Human Microbiota

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Effect of Tube Feeding on LCPUFAs Delivery

Human Milk | Lipid Depletion | Tube Feeding

Italy
Università degli Studi di Ferrara

Unknown

Human Milk Lipid Profile Assessment and Influences of Mother's Diet

Diet Habit | Breastfeeding | Human Milk | Infant Growth | Fatty Acid

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Unknown

Protein Balance and Body Composition in Preterm Infants

PreTerm Birth | Human Milk

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis (SAVE-D)

Hepatitis D

Italy
Hoffmann-La Roche

Terminated

A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

Influenza

Italy
Opera CRO, a TIGERMED Group Company

Completed

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

Influenza

Italy
Crucell Holland BV

Completed

A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Crucell Holland BV

Completed

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Influenza

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Seasonal Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD) (D-SHIELD)

Hepatitis D

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy (HEP4Di)

Hepatitis D

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

Interpandemic Influenza

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Influenza Vaccine | Cost-Benefit Analysis

Italy
University Of Perugia

Completed

Influenza Vaccination and Oral Anticoagulant Therapy

Influenza Vaccines | Anticoagulants

Italy
Novartis Vaccines

Completed

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Influenza A (H1N1)

Italy
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

Hepatitis D, Chronic

Italy
IRCCS San Raffaele
Hoffmann-La Roche; Abbott

Unknown

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

HIV Infections | Hepatitis C

Italy
Istituto Superiore di Sanità

Completed

Observational Study in HCV Chronic Infection

Hepatitis C, Chronic

Italy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Completed

Surgical Planning and Informed Consent (SPLICE)

Communication | Health Knowledge, Attitudes, Practice | Informed Consent | Patient Compliance | Patient-Centered Care | User-Computer Interface | Neurosurgery | Physician-Patient Relations | Humans | Feedback, Psychological

Italy
University of Roma La Sapienza

Completed

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

Hepatitis C

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

Influenza Disease

Italy
University of Milan

Recruiting

ECCO2R - Mechanical Power Study

ARDS, Human | Extracorporeal CO2 Removal | Mechanical Power

Italy
ReiThera Srl
European Commission

Completed

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients (HCV004)

Hepatitis C

Italy
Novartis Vaccines

Completed

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

Influenza Disease

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza

Italy
Azienda Ospedaliero-Universitaria di Parma
AbbVie

Completed

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

Chronic Hepatitis C

Italy
Azienda Ospedaliero-Universitaria di Parma

Completed

Effect of Boceprevir on HCV-specific T Cell Responses (Boce-Par)

Chronic Hepatitis C

Italy
Azienda Ospedaliera San Camillo Forlanini

Completed

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b (genotype)

Chronic Hepatitis C

Italy
Implicit Bioscience

No longer available

Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)

COVID | SARS-CoV2 | ARDS, Human | Ards

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Avian Influenza

Italy
University of Bari

Completed

Autoantibodies and Direct-acting Antivirals (BIOEPA)

Viral Hepatitis C | Therapy Adverse Effect

Italy
Catholic University of the Sacred Heart

Unknown

Steroids in Patients With Early ARDS

Acute Lung Injury | ARDS, Human

Italy
IRCCS San Raffaele
Hoffmann-La Roche; Abbott

Unknown

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

HIV Infections | Hepatitis C

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Influenza

Italy
Alessandra Mangia

Completed

Puglia HCV Micro-elimination Program (PHCVM)

Hepatitis C

Italy
University of Modena and Reggio Emilia

Unknown

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Chronic Hepatitis, C Virus

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Pandemic Influenza Disease

Italy
Rottapharm
Azienda Ospedaliera Universitaria Policlinico

Terminated

Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients (LEG-SIL-LTX-02)

Hepatitis C Virus Recurrence

Italy
University Hospital of Ferrara

Completed

Autoimmune Hepatitis in Pediatric Patients

Autoimmune Hepatitis

Italy
University of Milano Bicocca

Recruiting

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage (AIH Database)

Autoimmune Hepatitis | Liver Disorder

Italy
University of Turin, Italy

Unknown

Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

Chronic Hepatitis C

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine (CoVFlu)

COVID-19 | Influenza

Italy

3

Subscribe